Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
When a compounded preparation is clinically appropriate, it is prescribed only after an evaluation and labs, dispensed by a licensed 503A or 503B US pharmacy, and limited to substances the FDA currently permits on its 503A bulks list
Form & Stability Lyophilized peptide for research purposes Store refrigerated (28 C) and protect from light Reconstitute under sterile conditions before use Disclaimer This compound is intended for laboratory and scientific research only
Pregnancy and breastfeeding are off the protocol
Key Benefits of Retatrutide 12.5mg + Cagrilintide 2.5mg Next-Gen Weight Loss & Diabetes Peptide This combination is designed to target appetite and metabolic control through complementary pathways
